Approved and marketed in China by Bio-Thera (Brand Name:QLETLI®格乐立®)
• 2nd biosimilar and 1st Humira biosimilar approved in China
Biological Drug Product, Formulation, mAb Formulation
Adalimumab (Humira®) biosimilar
Related products
-
FormulationPropofol Injection
-
Chemical Drug ProductTirzepatide Injection(multi-dose)(Mounjaro,Zepbound)
Indications:Glycemic Control,Weight Management
-
-
Formulation
Sevoflurane Inhalation